Rchr
J-GLOBAL ID：201901021252773285   Update date: Aug. 27, 2023

Sato Seiya

サトウ セイヤ | Sato Seiya
Affiliation and department：
Shimane University

About Shimane University


Research field  (1)： Obstetrics and gynecology
Research keywords  (3)： 子宮がんの予防 ,  3次元培養 ,  婦人科悪性腫瘍
Research theme for competitive and other funds  (5)：
  • 2022 - 2025 正常子宮内膜上皮幹細胞におけるde novo遺伝子変異の発癌における意義
  • 2019 - 2022 卵巣明細胞癌に対するNEFHを標的とした新規治療法の開発
  • 2016 - 2019 The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinoma
  • 2013 - 2016 Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary
  • 2012 - 2015 Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
Papers (83)：
  • 菅野 晃輔, 中山 健太郎, 大西 薫, 石川 雅子, 石橋 朋佳, 山下 瞳, ラジア・スルタナ, 佐藤 誠也, 京 哲. BRAF V600E変異を有する粘液性境界卵巣腫瘍は浸潤癌への進行リスクが低い(Mucinous Borderline Ovarian Tumors with BRAF V600E Mutation May Have Low Risk for Progression to Invasive Carcinomas). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 203-203
  • 中山 健太郎, 石川 雅子, 山下 瞳, 石橋 朋佳, 菅野 晃輔, 島田 愛里香, 中川 恭子, スルタナラジア・プジャデイ, 佐藤 誠也, 京 哲. ゲノム医療の展開 卵巣低異型度漿液性癌の包括的解析と新たな治療戦略. 日本臨床細胞学会中国四国連合会会報. 2022. 36. 31-31
  • Kamrunnahar Shanta, Kentaro Nakayama, Mohammad Mahmud Hossain, Sultana Razia, Tomoka Ishibashi, Masako Ishikawa, Hitomi Yamashita, Kosuke Kanno, Seiya Sato, Satoru Nakayama, et al. Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines. Current oncology (Toronto, Ont.). 2022. 29. 6. 4020-4033
  • Satoru Kyo, Kosuke Kanno, Masahiro Takakura, Hitomi Yamashita, Masako Ishikawa, Tomoka Ishibashi, Seiya Sato, Kentaro Nakayama. Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance. Cancers. 2022. 14. 10
  • Hiroki Sasamori, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Ritsuto Fujiwaki, et al. Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients. Current oncology (Toronto, Ont.). 2022. 29. 5. 3658-3667
ｍore...
MISC (260)：
ｍore...
Education (1)：
  • 2005 - 2009 Post graduate course, Tottori University School of Medicine
Professional career (1)：
  • 博士(医学)
Work history (3)：
  • 2019/08 - 現在 Shimane University School of Medicine Obstetrics and Gynecology Assistant Professor
  • 2015/10 - 2019/08 Iwate Medical University School of Medicine Obstetrics and Gynecology Assistant Professor
  • 2011/10 - 2015/09 Tottori University School of Medicine Obstetrics and Gynecology Assistant Professor
Committee career (4)：
  • 2020/07 - 現在 日本産科婦人科学会・日本産婦人科医会 産婦人科診療ガイドライン婦人科外来編2023作成委員会委員
  • 2019/02 - 現在 日本産婦人科医会 研修委員会委員
  • 2019/06 - 2021/06 日本臨床細胞学会 利益相反委員会幹事
  • 2018/09 - 2020 日本婦人科腫瘍学会 卵巣がん治療ガイドライン2020年版作成委員
Association Membership(s) (6)：
日本臨床細胞学会 ,  JAPAN SOCIETY OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY AND MINIMALLY INVASIVE THERAPY ,  THE JAPANESE CANCER ASSOCIATION ,  JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  Japan Society of Gynecologic Oncology ,  JAPAN SOCIETY OF OBSTETRICS AND GYNECOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM